메뉴 건너뛰기




Volumn 26, Issue 3, 2015, Pages e46-e48

A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab

Author keywords

Adverse events; Drug associated uveitis; Pembrolizumab

Indexed keywords

DIFLUPREDNATE; HYDROCORTISONE; PEMBROLIZUMAB; ANTINEOPLASTIC AGENT; FLUPREDNISOLONE; GLUCOCORTICOID; MONOCLONAL ANTIBODY;

EID: 84963894720     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000724     Document Type: Article
Times cited : (74)

References (6)
  • 3
    • 84908354848 scopus 로고    scopus 로고
    • Anti-programmed-deathreceptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial
    • Robert C, Ribas A, Wolchok JD, et al. Anti-programmed-deathreceptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial. Lancet. 2014;384 (9948):1109-1117.
    • (2014) Lancet , vol.384 , Issue.9948 , pp. 1109-1117
    • Robert, C.1    Ribas, A.2    Wolchok, J.D.3
  • 4
  • 5
    • 84974663028 scopus 로고    scopus 로고
    • Pancreatitis secondary to anti-programmed death receptor 1 immunotherapy diagnosed by FDG PET/CT
    • Alabed YZ, Aghayev A, Sakellis C, Van den Abbeele AD. Pancreatitis secondary to anti-programmed death receptor 1 immunotherapy diagnosed by FDG PET/CT. Clin Nucl Med 2015; 40 (11): e528-e529.
    • (2015) Clin Nucl Med , vol.40 , Issue.11
    • Alabed, Y.Z.1    Aghayev, A.2    Sakellis, C.3    Van Den Abbeele, A.D.4
  • 6
    • 84940498365 scopus 로고    scopus 로고
    • Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma
    • Metcalfe W, Anderson J, Trinh VA, Hwu WJ. Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma. Discov Med. 2015; 19 (106): 393-401.
    • (2015) Discov Med , vol.19 , Issue.106 , pp. 393-401
    • Metcalfe, W.1    Erson, J.2    Trinh, V.A.3    Hwu, W.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.